• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Methicillin Resistant Staphylococcus aureus (MRSA) 


    The goals of ABCs surveillance are:

    To determine the incidence and epidemiologic characteristics of invasive disease due to Neisseria meningitidis, Haemophilus influenzae, Group A Streptococcus (Streptococcus pyogenes), Group B Streptococcus (Streptococcus agalactiae), Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus (MRSA) in the state of Maryland.
    To determine molecular epidemiologic patterns and microbiologic characteristics of public health relevance for isolates causing the above invasive infections.
    To provide an infrastructure for and to conduct additional special studies including those aimed at identifying risk factors for disease, evaluating prevention policies, and estimating the rate of subsequent disease among household members.
    ABCs Core activities and Catchment Areas

    The MD ABCs core surveillance activities include:

    Surveillance for Streptococcus pneumoniae and Group A Streptococcus (GAS) in the Baltimore Metropolitan Area (BMA). The BMA includes Baltimore City and its five surrounding counties (Anne Arundel, Baltimore, Carroll, Harford and Howard).
    Surveillance for Haemophilus influenzae, Neisseria meningitidis, and Group B Streptococcus (GBS) statewide.
    Surveillance for invasive methicillin-resistant Staphylococcus aureus (MRSA) in Baltimore City and Baltimore County.

    ABCs Case Ascertainment

    The MD ABCs identifies cases through:

    Reporting: Infection Control and Laboratory professionals at hospitals and laboratories serving residents in the catchment areas report cases identified at their facility. Cases are reported by faxing a completed "ABCs Notification Form" to 410-223-1815 or by calling 410-223-1801.
    Laboratory audits: To ensure the completeness of surveillance, the MD ABCs conducts monthly audits at the majority of reporting laboratories to identify cases not previously reported.
    Additional MD ABCs surveillance in Maryland

    In addition to core surveillance activities the MD ABCs conducts surveillance for:

    Candidemia: The MD ABCs conducts active population-based surveillance for cases of candidemia and antifungal drug resistance in Baltimore City and County.
    For more information about ABCs activities, including current Case Definitions and Surveillance Methodology, please visit the CDC ABCs website.


    Maryland Emerging Infections Program/ABCs
    Johns Hopkins University Bloomberg School of Public Health
    Candler Building
    111 Market Place, Suite 850, Room 8546
    Baltimore, MD 21202
    Phone: 410-223-1801
    Fax:  410-223-1815